Brubotics Rehabilitation Research center
Jette, Brussels Capital, 1090, Belgium
NCT Number: NCT05461677
The current study aims to investigate the effect of walking with the SAIRE smart walker on spatiotemporal parameters and gait kinematics in a population who suffer from difficulties during gait, and compare this to walking with a standard walker or no walking aid.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Jette, Brussels Capital, 1090, Belgium
This study is an experimental single group study investigating the effect of walking with a smart walker compared to walking with a standard walker or no walking aid in persons who suffer from gait difficulties. Participants will perform one session of walking in three different conditions, (1) walking with the SAIRE smart walker, (2) walking with a standard walker and (3) if the participants are able to walk without the use of an assistive device, walking without a walker. During this session, gait parameters will be compared between the three conditions.
Experimental session: During the experimental session, participants will walk along the 10-meter walkway (5 times for every condition) After every 5 trials, a rest period of minimum 5 minutes will be held to avoid fatigue. Three different walking conditions will be measured: (1) walking with the SAIRE smart walker, (2) walking with a standard walker and if possible (3) walking with no walking aid. Each walking condition will be measured five consecutive times in a randomized order. The order of the conditions will be randomized using closed envelopes containing notes that say what order of conditions will be used. This randomization is done to avoid fatigue effects that might occur when a strict order is used.
Before the start of the experimental session, participants will practice using the SAIRE smart walker for maximum 10 minutes to familiarize with the feedback given by the walker. After this familiarization session, the surface electrodes and reflective markers will be placed on the participants and the experimental session will start.
Analysis: This study will investigate the difference in gait biomechanics of adults with gait difficulties while using different walking aids.
Descriptive statistics of the baseline characteristics of all participants will be performed. The effect of gait with a smart walker on spatiotemporal gait parameters, kinematics and muscle activity will be compared to gait with a standard 2-wheeled walker and gait without a walking aid. Data will be visualized using LO(W)ESS smoothing (locally weighted scatterplot smoothing) to explore the effect (per condition and outcome). Values will be compared between conditions in a one-way repeated measures analysis of variance. For the analysis of the USE questionnaire, percentage distribution of every item and mean scores for every subscale will be calculated using Microsoft Excel (Microsoft, Washington, DC).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will walk along the 10-meter walkway 5 times using the SAIRE smart walker
Participants will walk along the 10-meter walkway 5 times using a standard 4-wheeled walker
Participants will walk along the 10-meter walkway 5 times without using a walking aid
Time frame: At the end of the experimental session, Day 1
Kinematic data (i.e., movement amplitudes of the bilateral hip, knee and ankle joint) of the lower limbs during walking will be recorded continuously with the use of a 14-camera Vicon Vero 1.3 system at 100 Hz.
Time frame: At the end of the experimental session, Day 1
Walking speed will be recorded continuously with the use of a 14-camera Vicon Vero 1.3 system at 100 Hz.
Time frame: At the end of the experimental session, Day 1
Cadence will be recorded continuously with the use of a 14-camera Vicon Vero 1.3 system at 100 Hz.
Time frame: At the end of the experimental session, Day 1
Step length will be recorded continuously with the use of a 14-camera Vicon Vero 1.3 system at 100 Hz.
Time frame: At the end of the experimental session, Day 1
Step time will be recorded continuously with the use of a 14-camera Vicon Vero 1.3 system at 100 Hz.
Time frame: At the end of the experimental session, Day 1
Swing time of the lower limbs during walking will be recorded continuously with the use of a 14-camera Vicon Vero 1.3 system at 100 Hz.
Time frame: At the end of the experimental session, Day 1
Stance time of the lower limbs during walking will be recorded continuously with the use of a 14-camera Vicon Vero 1.3 system at 100 Hz.
Time frame: At the end of the experimental session, Day 1
Single limb support period will be recorded continuously with the use of a 14-camera Vicon Vero 1.3 system at 100 Hz.
Time frame: At the end of the experimental session, Day 1
Double limb support period will be recorded continuously with the use of a 14-camera Vicon Vero 1.3 system at 100 Hz.
Time frame: At the end of the experimental session, Day 1
Muscle activity of the lower limb muscles (bilateral: M. rectus femoris, M. vastus lateralis, M. biceps femoris, M. tibialis anterior, M. gastrocnemius medialis) will be recorded continuously during treadmill walking with the use of surface electrodes. Signals will be recorded with the wireless Cometa Wave Plus EMG system (16 channels).
Time frame: At the end of the experimental session, Day 1
User experience will be assessed using a translated version of the self-administered Usefulness, Satisfaction and Ease of use (USE) questionnaire. This scale ranges from 30 to 210, with a higher score translating to higher satisfaction. Additionally, open questions were added to the questionnaire to uncover possible barriers and facilitators in the use of the smart walker.
Vrije Universiteit Brussel
Other
Acronym: SAIRE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07137403
Gait Disorders in Old Age, Gait Disorders, Neurologic
Umeå, Sweden
View Trial DetailsNCT03452488
Atrophy, Gait Disorders in Old Age
Banning, California, United States
View Trial DetailsNCT05459584
Arthritis, Balance; Distorted
Rome, Italy
View Trial DetailsNCT05723822
Cognition Disorders, Cognitive Decline
Minneapolis, Minnesota, United States
View Trial Details